Robuta

https://www.scirp.org/journal/PaperInformation?PaperID=82015&
Discover the significance of circulating tumor DNA (ctDNA) in early-stage breast cancer. Learn how PIK3CA mutations can serve as indicators for tumor burden...
circulating tumor dnadetectionmutation
https://www.preprints.org/manuscript/202403.0467/v1
Recent advancements in molecular diagnostics have highlighted the potential of circulating cell-free DNA (ccfDNA) as a biomarker in various diseases. This...
exploringrolecellfreedna
https://curie.fr/publications/circulating-tumor-dna-and-circulating-tumor-cells-metastatic-triple-negative-breast-cancer-patients
Retrouvez Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients. L'Institut Curie est le 1er centre de...
circulating tumor dnacellsmetastatictriple
https://pubmed.ncbi.nlm.nih.gov/33744389/
The paucity of targeted treatments available in patients with RAS mutant colorectal cancers contributes to the poor prognosis of this patient group compared to...
wild typetrueconversionsrasmutant
https://pubmed.ncbi.nlm.nih.gov/39785866/
These results demonstrate the clinical validity of ultrasensitive ctDNA detection and monitoring using SVs. Prospective trials are required to evaluate...
circulating tumor dnadetectionmonitoringusingstructural
https://pubmed.ncbi.nlm.nih.gov/41420893/
This systematic review and meta-analysis demonstrates that perioperative detection of ctDNA positivity is significantly associated with worse PFS and could...
circulating tumor dnaendometrial cancerprognosticvalueperioperative
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00170/full
Background: anti-EGFR antibodies are a standard care for advanced KRAS-wild type colorectal cancers. Circulating tumor DNA (ctDNA) monitoring during therapy ...
circulating tumor dnafrontiersdetectionmanagementanti
https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1125970/full
Abstract:Background: In recent years, tumor immunotherapy has become a viable treatment option for triple negative breast cancer (TNBC). Among these, immune ...
circulating tumor dnapredictive valuefrontierspotentialctdna
https://www.qiagen.com/us/resources/resourcedetail?id=5b234533-bfa0-4640-91da-c215940149c1&lang=sv-SE
circulating dnakit instructionssvdspuse
https://pubmed.ncbi.nlm.nih.gov/33320961/
Circulating cell-free DNA (cfDNA) has spurred much interest as a biomarker in oncology. However, inter- and intra-individual cfDNA levels vary greatly....
reference intervalsagestratifiedunlockclinical
https://pubmed.ncbi.nlm.nih.gov/28450972/
non invasiveinsulindnapotentialbiomarker
https://www.healthday.com/healthpro-news/cancer/circulating-tumor-hpv-dna-can-id-hpvopscc-years-before-diagnosis
Circulating tumor human papillomavirus DNA can be detected in the blood years prior to HPV-associated oropharyngeal squamous cell carcinoma diagnosis.
hpv dnatumoridopsccyears
https://www.qiagen.com/us/resources/resourcedetail?id=1197e1b5-dbb2-4f6f-9ef1-dcba4d0c22ce&lang=sk-SK
circulating dnakit instructionsskdspuse
https://www.aging-us.com/figure/202888/f5
Comparison of ctDNA among patients with different (A) breast cancer stages and (B) molecular subtypes. The means of each group are represented by black lines...
breast cancergeneticlandscapemutationtracking
https://www.prnewswire.com/news-releases/natera-chosen-for-longitudinal-circulating-tumor-dna-study-in-breast-cancer-300547101.html
/PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Imperial College...
circulating tumor dnanaterachosenlongitudinalstudy
https://www.preprints.org/manuscript/202012.0257
As non-operative management (NOM) of esophageal and rectal cancer is becoming more prevalent, blood-biomarkers such as circulating tumor DNA (ctDNA) may...
circulating tumor dnafeasibilitypatientspecificmonitoring